Graft-derived cell-free DNA as a marker of graft integrity after transplantation-Reference-Cited by-同舟云学术

Graft-derived cell-free DNA as a marker of graft integrity after transplantation

Published:2016 Issue: Volume: Page:153-176
ISSN:
Container-title:Personalized Immunosuppression in Transplantation
language:
Short-container-title:

Author:

Oellerich Michael,Beck Julia,Kanzow Philipp,Schmitz Jessica,Kollmar Otto,Walson Philip D.,Schütz Ekkehard

Publisher

Elsevier

Reference62 articles.

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR. 2010; Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.

2. Eurotransplant International Foundation. Annual Report 2012, [accessed 08.05.14].

3. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy;Taylor;Crit Rev Oncol Hematol,2005

4. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice;Kahan;Clin Ther,2002

5. MicroRNAs as biomarkers in solid organ transplantation;Mas;Am J Transplant,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation;Liver Transplantation;2021-10-04

2. Banking on Blockchain: An Evaluation of Innovation Decision Making;IEEE Transactions on Engineering Management;2020-11

3. Some simple economics of the blockchain;Communications of the ACM;2020-06-18

4. Immunologic Monitoring to Personalize Immunosuppression After Liver Transplant;Gastroenterology Clinics of North America;2018-06

5. Therapeutic drug monitoring – Key to personalized pharmacotherapy;Clinical Biochemistry;2017-05